Global Cell and Gene Therapy Manufacturing Services Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Allogeneic
  • 1.2.3 Autologous
  • 1.2.4 Viral Vector
• 1.3 Market by Application
  • 1.3.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Oncology Diseases
  • 1.3.3 Cardiovascular Diseases
  • 1.3.4 Orthopedic Diseases
  • 1.3.5 Ophthalmology Diseases
  • 1.3.6 Infectious Diseases
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cell and Gene Therapy Manufacturing Services Market Perspective (2017-2028)
• 2.2 Cell and Gene Therapy Manufacturing Services Growth Trends by Region
  • 2.2.1 Cell and Gene Therapy Manufacturing Services Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Cell and Gene Therapy Manufacturing Services Historic Market Size by Region (2017-2022)
  • 2.2.3 Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Region (2023-2028)
• 2.3 Cell and Gene Therapy Manufacturing Services Market Dynamics
  • 2.3.1 Cell and Gene Therapy Manufacturing Services Industry Trends
  • 2.3.2 Cell and Gene Therapy Manufacturing Services Market Drivers
  • 2.3.3 Cell and Gene Therapy Manufacturing Services Market Challenges
  • 2.3.4 Cell and Gene Therapy Manufacturing Services Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue
  • 3.1.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue (2017-2022)
  • 3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2017-2022)
• 3.2 Global Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing Services Revenue
• 3.4 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio
  • 3.4.1 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Services Revenue in 2021
• 3.5 Cell and Gene Therapy Manufacturing Services Key Players Head office and Area Served
• 3.6 Key Players Cell and Gene Therapy Manufacturing Services Product Solution and Service
• 3.7 Date of Enter into Cell and Gene Therapy Manufacturing Services Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Manufacturing Services Breakdown Data by Type

• 4.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Type (2017-2022)
• 4.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Type (2023-2028)

5 Cell and Gene Therapy Manufacturing Services Breakdown Data by Application

• 5.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Application (2017-2022)
• 5.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
• 6.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type
  • 6.2.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
  • 6.2.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
  • 6.2.3 North America Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
• 6.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Application
  • 6.3.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
  • 6.3.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
  • 6.3.3 North America Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
• 6.4 North America Cell and Gene Therapy Manufacturing Services Market Size by Country
  • 6.4.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
  • 6.4.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
• 7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type
  • 7.2.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
  • 7.2.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
  • 7.2.3 Europe Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
• 7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application
  • 7.3.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
  • 7.3.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
  • 7.3.3 Europe Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
• 7.4 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country
  • 7.4.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
  • 7.4.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
• 8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type
  • 8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application
  • 8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region
  • 8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
• 9.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type
  • 9.2.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
  • 9.2.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
  • 9.2.3 Latin America Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
• 9.3 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application
  • 9.3.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
  • 9.3.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
  • 9.3.3 Latin America Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
• 9.4 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country
  • 9.4.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
  • 9.4.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
• 10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type
  • 10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application
  • 10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country
  • 10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.1.5 Thermo Fisher Scientific Recent Developments
• 11.2 Merck KGaA
  • 11.2.1 Merck KGaA Company Details
  • 11.2.2 Merck KGaA Business Overview
  • 11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Introduction
  • 11.2.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.2.5 Merck KGaA Recent Developments
• 11.3 Charles River Laboratories
  • 11.3.1 Charles River Laboratories Company Details
  • 11.3.2 Charles River Laboratories Business Overview
  • 11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Introduction
  • 11.3.4 Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.3.5 Charles River Laboratories Recent Developments
• 11.4 Lonza
  • 11.4.1 Lonza Company Details
  • 11.4.2 Lonza Business Overview
  • 11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Introduction
  • 11.4.4 Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.4.5 Lonza Recent Developments
• 11.5 Catalent
  • 11.5.1 Catalent Company Details
  • 11.5.2 Catalent Business Overview
  • 11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Introduction
  • 11.5.4 Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.5.5 Catalent Recent Developments
• 11.6 WuXi AppTec
  • 11.6.1 WuXi AppTec Company Details
  • 11.6.2 WuXi AppTec Business Overview
  • 11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Introduction
  • 11.6.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.6.5 WuXi AppTec Recent Developments
• 11.7 Takara Bio Inc
  • 11.7.1 Takara Bio Inc Company Details
  • 11.7.2 Takara Bio Inc Business Overview
  • 11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Introduction
  • 11.7.4 Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.7.5 Takara Bio Inc Recent Developments
• 11.8 Nikon Corporation
  • 11.8.1 Nikon Corporation Company Details
  • 11.8.2 Nikon Corporation Business Overview
  • 11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Introduction
  • 11.8.4 Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.8.5 Nikon Corporation Recent Developments
• 11.9 FUJIFILM Holdings Corporation
  • 11.9.1 FUJIFILM Holdings Corporation Company Details
  • 11.9.2 FUJIFILM Holdings Corporation Business Overview
  • 11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Introduction
  • 11.9.4 FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.9.5 FUJIFILM Holdings Corporation Recent Developments
• 11.10 F. Hoffmann-La Roche
  • 11.10.1 F. Hoffmann-La Roche Company Details
  • 11.10.2 F. Hoffmann-La Roche Business Overview
  • 11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Introduction
  • 11.10.4 F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.10.5 F. Hoffmann-La Roche Recent Developments
• 11.11 Oxford Biomedica Plc
  • 11.11.1 Oxford Biomedica Plc Company Details
  • 11.11.2 Oxford Biomedica Plc Business Overview
  • 11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Introduction
  • 11.11.4 Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.11.5 Oxford Biomedica Plc Recent Developments
• 11.12 Cell and Gene Therapy Catapult
  • 11.12.1 Cell and Gene Therapy Catapult Company Details
  • 11.12.2 Cell and Gene Therapy Catapult Business Overview
  • 11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Introduction
  • 11.12.4 Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.12.5 Cell and Gene Therapy Catapult Recent Developments
• 11.13 The Discovery Labs LLC
  • 11.13.1 The Discovery Labs LLC Company Details
  • 11.13.2 The Discovery Labs LLC Business Overview
  • 11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Introduction
  • 11.13.4 The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.13.5 The Discovery Labs LLC Recent Developments
• 11.14 RoslinCT
  • 11.14.1 RoslinCT Company Details
  • 11.14.2 RoslinCT Business Overview
  • 11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Introduction
  • 11.14.4 RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.14.5 RoslinCT Recent Developments
• 11.15 JRS PHARMA
  • 11.15.1 JRS PHARMA Company Details
  • 11.15.2 JRS PHARMA Business Overview
  • 11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Introduction
  • 11.15.4 JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.15.5 JRS PHARMA Recent Developments
• 11.16 FinVector
  • 11.16.1 FinVector Company Details
  • 11.16.2 FinVector Business Overview
  • 11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Introduction
  • 11.16.4 FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.16.5 FinVector Recent Developments
• 11.17 ABL
  • 11.17.1 ABL Company Details
  • 11.17.2 ABL Business Overview
  • 11.17.3 ABL Cell and Gene Therapy Manufacturing Services Introduction
  • 11.17.4 ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.17.5 ABL Recent Developments
• 11.18 Resilience
  • 11.18.1 Resilience Company Details
  • 11.18.2 Resilience Business Overview
  • 11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Introduction
  • 11.18.4 Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.18.5 Resilience Recent Developments
• 11.19 BioCentriq
  • 11.19.1 BioCentriq Company Details
  • 11.19.2 BioCentriq Business Overview
  • 11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Introduction
  • 11.19.4 BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.19.5 BioCentriq Recent Developments
• 11.20 Porton Biopharma Limited
  • 11.20.1 Porton Biopharma Limited Company Details
  • 11.20.2 Porton Biopharma Limited Business Overview
  • 11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Introduction
  • 11.20.4 Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.20.5 Porton Biopharma Limited Recent Developments
• 11.21 Andelyn Biosciences
  • 11.21.1 Andelyn Biosciences Company Details
  • 11.21.2 Andelyn Biosciences Business Overview
  • 11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Introduction
  • 11.21.4 Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.21.5 Andelyn Biosciences Recent Developments
• 11.22 Commercializing Living Therapies
  • 11.22.1 Commercializing Living Therapies Company Details
  • 11.22.2 Commercializing Living Therapies Business Overview
  • 11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Introduction
  • 11.22.4 Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.22.5 Commercializing Living Therapies Recent Developments
• 11.23 Vibalogics
  • 11.23.1 Vibalogics Company Details
  • 11.23.2 Vibalogics Business Overview
  • 11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Introduction
  • 11.23.4 Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.23.5 Vibalogics Recent Developments
• 11.24 Anemocyte Srl
  • 11.24.1 Anemocyte Srl Company Details
  • 11.24.2 Anemocyte Srl Business Overview
  • 11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Introduction
  • 11.24.4 Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.24.5 Anemocyte Srl Recent Developments
• 11.25 ElevateBio
  • 11.25.1 ElevateBio Company Details
  • 11.25.2 ElevateBio Business Overview
  • 11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Introduction
  • 11.25.4 ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 11.25.5 ElevateBio Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Allogeneic
• Table 3. Key Players of Autologous
• Table 4. Key Players of Viral Vector
• Table 5. Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 6. Global Cell and Gene Therapy Manufacturing Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 7. Global Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022) & (US$ Million)
• Table 8. Global Cell and Gene Therapy Manufacturing Services Market Share by Region (2017-2022)
• Table 9. Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 10. Global Cell and Gene Therapy Manufacturing Services Market Share by Region (2023-2028)
• Table 11. Cell and Gene Therapy Manufacturing Services Market Trends
• Table 12. Cell and Gene Therapy Manufacturing Services Market Drivers
• Table 13. Cell and Gene Therapy Manufacturing Services Market Challenges
• Table 14. Cell and Gene Therapy Manufacturing Services Market Restraints
• Table 15. Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2017-2022) & (US$ Million)
• Table 16. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Players (2017-2022)
• Table 17. Global Top Cell and Gene Therapy Manufacturing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2021)
• Table 18. Ranking of Global Top Cell and Gene Therapy Manufacturing Services Companies by Revenue (US$ Million) in 2021
• Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue (CR5 and HHI) & (2017-2022)
• Table 20. Key Players Headquarters and Area Served
• Table 21. Key Players Cell and Gene Therapy Manufacturing Services Product Solution and Service
• Table 22. Date of Enter into Cell and Gene Therapy Manufacturing Services Market
• Table 23. Mergers & Acquisitions, Expansion Plans
• Table 24. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & (US$ Million)
• Table 25. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Type (2017-2022)
• Table 26. Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 27. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Type (2023-2028)
• Table 28. Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & (US$ Million)
• Table 29. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Application (2017-2022)
• Table 30. Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 31. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Application (2023-2028)
• Table 32. North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & (US$ Million)
• Table 33. North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028) & (US$ Million)
• Table 34. North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & (US$ Million)
• Table 35. North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028) & (US$ Million)
• Table 36. North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
• Table 37. North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
• Table 38. Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & (US$ Million)
• Table 39. Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028) & (US$ Million)
• Table 40. Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & (US$ Million)
• Table 41. Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028) & (US$ Million)
• Table 42. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
• Table 43. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
• Table 44. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & (US$ Million)
• Table 45. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028) & (US$ Million)
• Table 46. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & (US$ Million)
• Table 47. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028) & (US$ Million)
• Table 48. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022) & (US$ Million)
• Table 49. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2023-2028) & (US$ Million)
• Table 50. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & (US$ Million)
• Table 51. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028) & (US$ Million)
• Table 52. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & (US$ Million)
• Table 53. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028) & (US$ Million)
• Table 54. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
• Table 55. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
• Table 56. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & (US$ Million)
• Table 57. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028) & (US$ Million)
• Table 58. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & (US$ Million)
• Table 59. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028) & (US$ Million)
• Table 60. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
• Table 61. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
• Table 62. Thermo Fisher Scientific Company Details
• Table 63. Thermo Fisher Scientific Business Overview
• Table 64. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product
• Table 65. Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 66. Thermo Fisher Scientific Recent Developments
• Table 67. Merck KGaA Company Details
• Table 68. Merck KGaA Business Overview
• Table 69. Merck KGaA Cell and Gene Therapy Manufacturing Services Product
• Table 70. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 71. Merck KGaA Recent Developments
• Table 72. Charles River Laboratories Company Details
• Table 73. Charles River Laboratories Business Overview
• Table 74. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product
• Table 75. Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 76. Charles River Laboratories Recent Developments
• Table 77. Lonza Company Details
• Table 78. Lonza Business Overview
• Table 79. Lonza Cell and Gene Therapy Manufacturing Services Product
• Table 80. Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 81. Lonza Recent Developments
• Table 82. Catalent Company Details
• Table 83. Catalent Business Overview
• Table 84. Catalent Cell and Gene Therapy Manufacturing Services Product
• Table 85. Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 86. Catalent Recent Developments
• Table 87. WuXi AppTec Company Details
• Table 88. WuXi AppTec Business Overview
• Table 89. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product
• Table 90. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 91. WuXi AppTec Recent Developments
• Table 92. Takara Bio Inc Company Details
• Table 93. Takara Bio Inc Business Overview
• Table 94. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product
• Table 95. Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 96. Takara Bio Inc Recent Developments
• Table 97. Nikon Corporation Company Details
• Table 98. Nikon Corporation Business Overview
• Table 99. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product
• Table 100. Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 101. Nikon Corporation Recent Developments
• Table 102. FUJIFILM Holdings Corporation Company Details
• Table 103. FUJIFILM Holdings Corporation Business Overview
• Table 104. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product
• Table 105. FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 106. FUJIFILM Holdings Corporation Recent Developments
• Table 107. F. Hoffmann-La Roche Company Details
• Table 108. F. Hoffmann-La Roche Business Overview
• Table 109. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product
• Table 110. F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 111. F. Hoffmann-La Roche Recent Developments
• Table 112. Oxford Biomedica Plc Company Details
• Table 113. Oxford Biomedica Plc Business Overview
• Table 114. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product
• Table 115. Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 116. Oxford Biomedica Plc Recent Developments
• Table 117. Cell and Gene Therapy Catapult Company Details
• Table 118. Cell and Gene Therapy Catapult Business Overview
• Table 119. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product
• Table 120. Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 121. Cell and Gene Therapy Catapult Recent Developments
• Table 122. The Discovery Labs LLC Company Details
• Table 123. The Discovery Labs LLC Business Overview
• Table 124. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product
• Table 125. The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 126. The Discovery Labs LLC Recent Developments
• Table 127. RoslinCT Company Details
• Table 128. RoslinCT Business Overview
• Table 129. RoslinCT Cell and Gene Therapy Manufacturing Services Product
• Table 130. RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 131. RoslinCT Recent Developments
• Table 132. JRS PHARMA Company Details
• Table 133. JRS PHARMA Business Overview
• Table 134. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product
• Table 135. JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 136. JRS PHARMA Recent Developments
• Table 137. FinVector Company Details
• Table 138. FinVector Business Overview
• Table 139. FinVector Cell and Gene Therapy Manufacturing Services Product
• Table 140. FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 141. FinVector Recent Developments
• Table 142. ABL Company Details
• Table 143. ABL Business Overview
• Table 144. ABL Cell and Gene Therapy Manufacturing Services Product
• Table 145. ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 146. ABL Recent Developments
• Table 147. Resilience Company Details
• Table 148. Resilience Business Overview
• Table 149. Resilience Cell and Gene Therapy Manufacturing Services Product
• Table 150. Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 151. Resilience Recent Developments
• Table 152. BioCentriq Company Details
• Table 153. BioCentriq Business Overview
• Table 154. BioCentriq Cell and Gene Therapy Manufacturing Services Product
• Table 155. BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 156. BioCentriq Recent Developments
• Table 157. Porton Biopharma Limited Company Details
• Table 158. Porton Biopharma Limited Business Overview
• Table 159. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product
• Table 160. Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 161. Porton Biopharma Limited Recent Developments
• Table 162. Andelyn Biosciences Company Details
• Table 163. Andelyn Biosciences Business Overview
• Table 164. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product
• Table 165. Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 166. Andelyn Biosciences Recent Developments
• Table 167. Commercializing Living Therapies Company Details
• Table 168. Commercializing Living Therapies Business Overview
• Table 169. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product
• Table 170. Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 171. Commercializing Living Therapies Recent Developments
• Table 172. Vibalogics Company Details
• Table 173. Vibalogics Business Overview
• Table 174. Vibalogics Cell and Gene Therapy Manufacturing Services Product
• Table 175. Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 176. Vibalogics Recent Developments
• Table 177. Anemocyte Srl Company Details
• Table 178. Anemocyte Srl Business Overview
• Table 179. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product
• Table 180. Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 181. Anemocyte Srl Recent Developments
• Table 182. ElevateBio Company Details
• Table 183. ElevateBio Business Overview
• Table 184. ElevateBio Cell and Gene Therapy Manufacturing Services Product
• Table 185. ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
• Table 186. ElevateBio Recent Developments
• Table 187. Research Programs/Design for This Report
• Table 188. Key Data Information from Secondary Sources
• Table 189. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Cell and Gene Therapy Manufacturing Services Market Share by Type: 2021 VS 2028
• Figure 2. Allogeneic Features
• Figure 3. Autologous Features
• Figure 4. Viral Vector Features
• Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Share by Application: 2021 VS 2028
• Figure 6. Oncology Diseases Case Studies
• Figure 7. Cardiovascular Diseases Case Studies
• Figure 8. Orthopedic Diseases Case Studies
• Figure 9. Ophthalmology Diseases Case Studies
• Figure 10. Infectious Diseases Case Studies
• Figure 11. Others Case Studies
• Figure 12. Cell and Gene Therapy Manufacturing Services Report Years Considered
• Figure 13. Global Cell and Gene Therapy Manufacturing Services Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 14. Global Cell and Gene Therapy Manufacturing Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 15. Global Cell and Gene Therapy Manufacturing Services Market Share by Region: 2021 VS 2028
• Figure 16. Global Cell and Gene Therapy Manufacturing Services Market Share by Players in 2021
• Figure 17. Global Top Cell and Gene Therapy Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2021)
• Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2021
• Figure 19. North America Cell and Gene Therapy Manufacturing Services Market Size YoY (2017-2028) & (US$ Million)
• Figure 20. North America Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2028)
• Figure 21. North America Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2028)
• Figure 22. North America Cell and Gene Therapy Manufacturing Services Market Size Share by Country (2017-2028)
• Figure 23. United States Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 24. Canada Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 25. Europe Cell and Gene Therapy Manufacturing Services Market Size YoY (2017-2028) & (US$ Million)
• Figure 26. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2028)
• Figure 27. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2028)
• Figure 28. Europe Cell and Gene Therapy Manufacturing Services Market Size Share by Country (2017-2028)
• Figure 29. Germany Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. France Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. U.K. Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Italy Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Russia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Nordic Countries Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 35. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size YoY (2017-2028) & (US$ Million)
• Figure 36. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2028)
• Figure 37. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2028)
• Figure 38. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Share by Region (2017-2028)
• Figure 39. China Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. Japan Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. South Korea Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. India Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 44. Australia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 45. Latin America Cell and Gene Therapy Manufacturing Services Market Size YoY (2017-2028) & (US$ Million)
• Figure 46. Latin America Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2028)
• Figure 47. Latin America Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2028)
• Figure 48. Latin America Cell and Gene Therapy Manufacturing Services Market Size Share by Country (2017-2028)
• Figure 49. Mexico Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 50. Brazil Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 51. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size YoY (2017-2028) & (US$ Million)
• Figure 52. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2028)
• Figure 53. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2028)
• Figure 54. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size Share by Country (2017-2028)
• Figure 55. Turkey Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. UAE Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 59. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 60. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 61. Lonza Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 62. Catalent Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 63. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 64. Takara Bio Inc Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 65. Nikon Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 66. FUJIFILM Holdings Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 67. F. Hoffmann-La Roche Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 68. Oxford Biomedica Plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 69. Cell and Gene Therapy Catapult Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 70. The Discovery Labs LLC Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 71. RoslinCT Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 72. JRS PHARMA Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 73. FinVector Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 74. ABL Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 75. Resilience Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 76. BioCentriq Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 77. Porton Biopharma Limited Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 78. Andelyn Biosciences Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 79. Commercializing Living Therapies Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 80. Vibalogics Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 81. Anemocyte Srl Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 82. ElevateBio Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
• Figure 83. Bottom-up and Top-down Approaches for This Report
• Figure 84. Data Triangulation
• Figure 85. Key Executives Interviewed